Skip to main content

RAFT-AF Trial

Jason Gencher presented the RAFT-AF Trial which was a randomized, multicenter, open-label trial comparing ablation-based rhythm control to rate control among patients with high-burden paroxysmal (>4 episodes in 6 months) or persistent (duration <3 years) AFib, NYHA…
Read More

APAF-CRT Mortality Trial

Jason Gencher presented the APAF-CRT Mortality Trial which was an international, open-label, blinded outcome trial of patients with severely symptomatic permanent atrial fibrillation for greater than 6 months, a narrow QRS (≤110 ms) and at least one HF…
Read More

RATE-AF Trial

Dr. Michael Thibert presented the RATE-AF Trial, which is a prospective, randomized, open-label, blinded, endpoint trial comparing the use of digoxin and beta-blockers as initial rate control therapy for permanent…
Read More